Ftse Mib
33.766,29
-0,06%
DAX
19.884,75
-0,57%
S&P 500
5.930,85
1,09%
NASDAQ
19.572,60
1,03%
Bitcoin
95.489,51
-1,77%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Altimmune Inc (ALT) Altimmune Inc (ALT) Notizie

Altimmune Inc

ALT
8,40
0,22 (2,69%)
21 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202413:30GLOBEAltimmune Added to Nasdaq Biotechnology Index
11/12/202423:19EDGAR2Form 8-K - Current report
02/12/202413:30GLOBEAltimmune to Present at the Cachexia Regulatory & Trials..
26/11/202413:30GLOBEAltimmune to Participate at Two Upcoming Investor..
15/11/202417:00GLOBEAltimmune Presents New Data on the Effect of Pemvidutide on..
12/11/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202413:00GLOBEAltimmune Announces Third Quarter 2024 Financial Results and..
12/11/202412:46EDGAR2Form 8-K - Current report
11/11/202413:30GLOBEAltimmune Appoints Life Sciences Industry Veteran Greg..
07/11/202413:30GLOBEAltimmune Announces Successful Completion of End-of-Phase 2..
06/11/202413:30GLOBEAltimmune to Participate at Two Upcoming Investor..
04/11/202413:30GLOBEAltimmune to Report Third Quarter 2024 Financial Results and..
15/10/202414:00GLOBEAltimmune to Present New Data on the Lipidomic Profile in..
01/10/202413:30GLOBEAltimmune to Participate in the H.C. Wainwright 8th Annual..
01/10/202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202400:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202400:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/9/202413:30GLOBEAltimmune Completes Enrollment in Phase 2b IMPACT Trial of..
26/9/202422:45EDGAR2Form 8-K - Current report
10/9/202419:09GLOBECORRECTION – Altimmune Presents Results of a Phase 2..
10/9/202413:45GLOBEAltimmune Presents Results of a Phase 2 MRI-Based Body..
03/9/202413:30GLOBEAltimmune Announces Oral Presentation of Pemvidutide..
21/8/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:14EDGAR2Form ARS - Annual Report to Security Holders
15/8/202422:08EDGAR2Form DEF 14A - Other definitive proxy statements
15/8/202422:03EDGAR2Form 8-K - Current report
08/8/202422:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202413:04EDGAR2Form 8-K - Current report
08/8/202413:00GLOBEAltimmune Announces Second Quarter 2024 Financial Results..
07/8/202413:00GLOBECytoSorbents to Report Second Quarter 2024 Operating and..
01/8/202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202423:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202423:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202413:30GLOBEAltimmune to Report Second Quarter 2024 Financial Results..
25/7/202413:30GLOBEAltimmune Announces Publication of Clinical Study of..
03/7/202411:45PRNUSLost Money on Altimmune, Inc.(ALT)? Join Class Action Suit..
02/7/202413:30GLOBEAltimmune to Participate at Leerink Partners Therapeutics..
28/6/202411:45PRNUSLost Money on Altimmune, Inc.(ALT)? Join Class Action Suit..
26/6/202413:30GLOBEAltimmune Mourns Passing of Chief Financial Officer, Richard..
25/6/202411:45PRNUSShareholders that lost money on Altimmune, Inc.(ALT) should..
23/6/202419:45GLOBEAltimmune Presents Data from Phase 2 MOMENTUM Trial of..
22/6/202422:45GLOBEAltimmune Presents Data on the Effect of Pemvidutide on..
20/6/202413:30GLOBEAltimmune to Participate in the Piper Sandler 2nd Annual..
20/6/202411:45PRNUSAltimmune, Inc. Securities Fraud Class Action Lawsuit..
18/6/202413:30GLOBEAltimmune Announces Oral Presentations of Pemvidutide..
17/6/202411:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
Apertura: 8,31 Min: 8,18 Max: 8,75
Chiusura: 8,18

La tua Cronologia

NASDAQ
ALT
Altimmune
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network